TAC4, tachykinin precursor 4, 255061

N. diseases: 24; N. variants: 1
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0030193
Disease: Pain
Pain
0.050 Biomarker phenotype BEFREE Hemokinin-1 is an important mediator of pain in mouse models of neuropathic and inflammatory mechanisms. 30664920 2019
CUI: C0030193
Disease: Pain
Pain
0.050 Biomarker phenotype BEFREE We hypothesize that thalamic mast cells contribute to inflammation and pain, by releasing neuro-sensitizing molecules that include histamine, IL-1β, IL-6 and TNF, as well as calcitonin-gene related peptide (CGRP), HK-1 and SP. 31427928 2019
CUI: C0030193
Disease: Pain
Pain
0.050 Biomarker phenotype BEFREE Due to its widespread distribution in the whole body, HK-1 is involved in different physiological and pathophysiological functions involving pain inflammation modulation, immune regulation, respiratory and endocrine functions, as well as tumor genesis. 27993375 2017
CUI: C0030193
Disease: Pain
Pain
0.050 Biomarker phenotype BEFREE A representative of the tachykinin peptide family is substance P (SP), and the function of SP has been well characterized as a pain transmitter or modulator, while it is possible that HK-1 is involved in pruriceptive processing, but, as yet, the distribution of HK-1 peptide in the trigeminal sensory system is still unknown. 28301818 2017
CUI: C0030193
Disease: Pain
Pain
0.050 Biomarker phenotype BEFREE Therefore the aim of this study was to investigate the effects of Endokinin A/B (EKA/B, the common C-terminal decapeptide in EKA and EKB) and Endokinin C/D (EKC/D, the common C-terminal duodecapeptide in EKC and EKD) on pain modulation at supraspinal level in mice.Intracerebroventricular (i.c.v.) administration of EKA/B (1, 3, 12, 20nmol/mouse) dose dependently induced potent analgesic effect. 19854230 2010